Company intelligence / Profile preview

KVK Tech

Newtown, Pennsylvania, United Stateskvktech.com ↗

Ownership: Private
Employees: ~300
Development stage: Other

Overview

KVK Tech manufactures and markets more than 25 FDA-approved generic medications in the United States. The company focuses on high-quality oral solids (including extended-release tablets) and sterile injectables. All non-sterile products are manufactured domestically in state-of-the-art facilities in Newtown, Pennsylvania.

Therapeutic areas: NeurologyCardiovascularOther
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

phentermine

Approved

Partnerships

Not publicly disclosed; maintains relationships with major pharmacy chains, wholesalers and distributors

Beyond the preview

Go deeper on KVK Tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KVK Tech.

Explore the full profile